HGHarry Glickman
Harry Glickman
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Harry Glickman has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Shirin A. Enger
Medical Physics Unit, Department of Oncology, Faculty of Medicine, McGill University, Montreal, Quebec, Canada
2 shared publications- Yujing Zou
Medical Physics Unit, Department of Oncology, Faculty of Medicine, McGill University, Montreal, Canada
2 shared publications - Alexandra Rink
Radiation Oncology, University of Toronto, Toronto, Ontario, Canada; Princess Margaret Cancer Centre, Medical Biophysics, Toronto, Canada
1 shared publication Amanda Cherpak
1 shared publicationAndrew Alexander
1 shared publication- Boris Bahoric
Department of Radiation Oncology, Jewish General Hospital, Montreal, Canada
1 shared publication
Latest Publications
- Open Access
- 27 July 2026
- Published by Elsevier in Advances in Radiation Oncology
- Vol. 11 (12) , 102140
Pan-Cancer Gene Expression Predicts Per-Cancer Radiation Therapy Response
- 27 July 2026
- Published by Elsevier in Advances in Radiation Oncology
- Vol. 11 (12) , 102140
Open AccessPan-Cancer Gene Expression Predicts Per-Cancer Radiation Therapy Response
- Open Access
- 1 May 2026
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 39
Trends in brachytherapy utilization in Canada from 2011 to 2020
- 1 May 2026
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 39
Open AccessTrends in brachytherapy utilization in Canada from 2011 to 2020
- Open Access
- 19 June 2025
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 35, 100793
Tumour nuclear size heterogeneity as a biomarker for post-radiotherapy outcomes in gynecological malignancies
- 19 June 2025
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 35, 100793
Open AccessTumour nuclear size heterogeneity as a biomarker for post-radiotherapy outcomes in gynecological malignancies